Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
BM

BMY

Market Closed

Bristol-Myers Squibb Company

NYSEHealthcareDrug Manufacturers - General
US
32.50K employees
CEO: Christopher Boerner
Founded: 1972
$63.43
+$0.00(+NaN%)
Market Cap
129.66B
Beta
0.23
52W Range
N/A
Dividend Yield
3.97%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Bristol-Myers Squibb’s current price at $62.91 is substantially below its PERT-weighted fair value of $131.50, indicating significant upside potential with high confidence. Strong profitability (5/5) and growth (4/5) support valuation, while low leverage (1/5) highlights financial risks. Monte Carlo analysis shows high volatility but no downside scenarios below the current price, suggesting asymmetric risk-return.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore BMY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BMY in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →